REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 49 filers reported holding REPARE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,048,716 | +13.1% | 2,404,695 | -1.0% | 1.38% | +40.2% |
| Q2 2023 | $25,691,784 | +3.1% | 2,428,335 | -4.1% | 0.99% | -8.8% |
| Q1 2023 | $24,925,212 | -36.9% | 2,533,050 | -5.6% | 1.08% | -33.1% |
| Q4 2022 | $39,487,465 | +21.3% | 2,684,396 | 0.0% | 1.62% | +27.9% |
| Q3 2022 | $32,562,000 | -14.5% | 2,684,396 | -1.3% | 1.26% | -13.1% |
| Q2 2022 | $38,067,000 | -2.2% | 2,720,996 | -0.4% | 1.45% | +19.7% |
| Q1 2022 | $38,918,000 | -33.8% | 2,732,996 | -2.0% | 1.22% | -9.1% |
| Q4 2021 | $58,830,000 | -12.7% | 2,789,496 | +8.6% | 1.34% | +13.8% |
| Q3 2021 | $67,376,000 | -17.7% | 2,567,696 | -2.2% | 1.18% | -3.0% |
| Q2 2021 | $81,829,000 | +0.0% | 2,624,396 | -1.5% | 1.21% | +5.1% |
| Q1 2021 | $81,804,000 | -9.9% | 2,665,496 | +0.7% | 1.15% | +4.7% |
| Q4 2020 | $90,816,000 | +22.7% | 2,647,696 | +10.1% | 1.10% | -19.1% |
| Q3 2020 | $74,001,000 | -0.0% | 2,404,974 | +0.8% | 1.36% | -0.5% |
| Q2 2020 | $74,019,000 | – | 2,386,174 | – | 1.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
| CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
| MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
| BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
| Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
| Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
| HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
| Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
| Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |